0001385508-23-000011.txt : 20230105
0001385508-23-000011.hdr.sgml : 20230105
20230105170345
ACCESSION NUMBER: 0001385508-23-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Toole David D
CENTRAL INDEX KEY: 0001491140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38193
FILM NUMBER: 23512331
MAIL ADDRESS:
STREET 1: 1640 MARENGO STREET
CITY: LOS ANGELES
STATE: CA
ZIP: 90033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001385508
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464744124
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 WILSHIRE BLVD
STREET 2: SUITE 400
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
BUSINESS PHONE: (310) 598-5410
MAIL ADDRESS:
STREET 1: 233 WILSHIRE BLVD
STREET 2: SUITE 400
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
FORMER COMPANY:
FORMER CONFORMED NAME: Lightlake Therapeutics Inc.
DATE OF NAME CHANGE: 20091009
FORMER COMPANY:
FORMER CONFORMED NAME: Madrona Ventures, Inc.
DATE OF NAME CHANGE: 20070108
4
1
wf-form4_167295619781599.xml
FORM 4
X0306
4
2023-01-05
0
0001385508
OPIANT PHARMACEUTICALS, INC.
OPNT
0001491140
O'Toole David D
C/O OPIANT PHARMACEUTICALS, INC.
233 WILSHIRE BOULEVARD, SUITE 400
SANTA MONICA
CA
90401
0
1
0
0
Chief Financial Officer
Common Stock
2023-01-05
4
S
0
1600
20.20
D
35204
D
These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
/s/ David D. O'Toole
2023-01-05